Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium in Ischemic Stroke Outcome
NCT02505295Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Oct 2015
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Randomised, double-blind trial in ischemic stroke, sponsored by Mazandaran University of Medical Sciences. Primary endpoints: National Institutes of Health Stroke Scale at 3 days and modified Rankin Scale at 8 days. Started Oct 2015; status: completed.
02
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02505295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02505295.